ILA — Island Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$96.17m
- AU$83.30m
- AU$0.28m
Australia's Island Pharmaceuticals jumps on buying antiviral program
Brief: Island Pharmaceuticals Seeks Trading Halt
Brief: Island Pharmaceuticals Appoints Jason Carroll As Non-Executive Chairman
Brief: Island Pharmaceuticals Seeks Trading Halt
Brief: Island Pharmaceuticals To Raise A$3.6 Mln Via Placement
Brief: Island Pharmaceuticals Seeks Trading Halt
Brief: Island Pharmaceuticals Says US Patent Granted For Isla-101
Australia's Island Pharmaceuticals rises on US patent for dengue drug
Brief: Island Pharmaceuticals Seeks Trading Halt
Brief: Island Pharmaceuticals Says Phillip Lynch Appointed Executive Chairman
Brief: Island Pharmaceuticals Says Paul Macleman To Retire As Executive Chair
Brief: Island Pharmaceuticals Announces Placement Of A$3.5M
Brief: Island Pharmaceuticals Seeks Trading Halt
Australia's Island Pharmaceuticals jumps on acquisition of antiviral molecule
Brief: Island Pharmaceuticals Signs Non-Binding Term Sheet With Biocryst
Brief: Island Pharmaceuticals Seeks Trading Halt
Brief: Island Pharmaceuticals Says A$1.95 Million Fully Underwritten Rights Issue
Brief: Island Pharmaceuticals Announces Non-Renounceable Pro-Rata Entitlement Offer
Brief: Island Pharmaceuticals Seeks Trading Halt